PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER DISEASES, CONTAINING PLASMALOGEN PRECURSOR, PLASMALOGEN OR PLASMALOGEN ANALOG AS EFFECTIVE COMPONENT
The present invention relates to a pharmaceutical composition for preventing or treating liver diseases, containing a plasmalogen precursor, plasmalogen, or a plasmalogen analog as an effective component. More specifically, a plasmalogen precursor, or plasmalogen or a plasmalogen analog produced by metabolizing the plasmalogen precursor, can prevent or treat liver diseases such as hepatic steatosis, hepatitis, or liver cirrhosis, etc. by decreasing accumulation of neutral fats in the liver, repressing expressions of inflammatory cytokine genes, and increasing fatty acid oxidation capacity of peroxisome.
